Validation of the IHE Cohort Model of Type 2 Diabetes and the Impact of Choice of Macrovascular Risk Equations
Author
Abstract
Suggested Citation
DOI: 10.1371/journal.pone.0110235
Download full text from publisher
References listed on IDEAS
- David M. Eddy & William Hollingworth & J. Jaime Caro & Joel Tsevat & Kathryn M. McDonald & John B. Wong, 2012. "Model Transparency and Validation," Medical Decision Making, , vol. 32(5), pages 733-743, September.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Michael Laxy & Verena Maria Schöning & Christoph Kurz & Rolf Holle & Annette Peters & Christa Meisinger & Wolfgang Rathmann & Kristin Mühlenbruch & Katharina Kähm, 2019. "Performance of the UKPDS Outcomes Model 2 for Predicting Death and Cardiovascular Events in Patients with Type 2 Diabetes Mellitus from a German Population-Based Cohort," PharmacoEconomics, Springer, vol. 37(12), pages 1485-1494, December.
- Michael Willis & Adam Fridhammar & Jens Gundgaard & Andreas Nilsson & Pierre Johansen, 2020. "Comparing the Cohort and Micro-Simulation Modeling Approaches in Cost-Effectiveness Modeling of Type 2 Diabetes Mellitus: A Case Study of the IHE Diabetes Cohort Model and the Economics and Health Out," PharmacoEconomics, Springer, vol. 38(9), pages 953-969, September.
- Michael Willis & Pierre Johansen & Andreas Nilsson & Christian Asseburg, 2017. "Validation of the Economic and Health Outcomes Model of Type 2 Diabetes Mellitus (ECHO-T2DM)," PharmacoEconomics, Springer, vol. 35(3), pages 375-396, March.
- Åsa Ericsson & Divina Glah & Maria Lorenzi & Jeroen P Jansen & Adam Fridhammar, 2018. "Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetes," PLOS ONE, Public Library of Science, vol. 13(2), pages 1-16, February.
- Pierre Johansen & Jonas Håkan-Bloch & Aiden R. Liu & Peter G. Bech & Sofie Persson & Lawrence A. Leiter, 2019. "Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada," PharmacoEconomics - Open, Springer, vol. 3(4), pages 537-550, December.
- Åsa Ericsson & Adam Lundqvist, 2017. "Cost Effectiveness of Insulin Degludec Plus Liraglutide (IDegLira) in a Fixed Combination for Uncontrolled Type 2 Diabetes Mellitus in Sweden," Applied Health Economics and Health Policy, Springer, vol. 15(2), pages 237-248, April.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Dimitris Bertsimas & John Silberholz & Thomas Trikalinos, 2018. "Optimal healthcare decision making under multiple mathematical models: application in prostate cancer screening," Health Care Management Science, Springer, vol. 21(1), pages 105-118, March.
- Harvard, Stephanie & Winsberg, Eric & Symons, John & Adibi, Amin, 2021. "Value judgments in a COVID-19 vaccination model: A case study in the need for public involvement in health-oriented modelling," Social Science & Medicine, Elsevier, vol. 286(C).
- Andrew J. Palmer & Julie A. Campbell & Barbara de Graaff & Nancy Devlin & Hasnat Ahmad & Philip M Clarke & Mingsheng Chen & Lei Si, 2021. "Population norms for quality adjusted life years for the United States of America, China, the United Kingdom and Australia," Health Economics, John Wiley & Sons, Ltd., vol. 30(8), pages 1950-1977, August.
- Matthew R Behrend & María-Gloria Basáñez & Jonathan I D Hamley & Travis C Porco & Wilma A Stolk & Martin Walker & Sake J de Vlas & for the NTD Modelling Consortium, 2020. "Modelling for policy: The five principles of the Neglected Tropical Diseases Modelling Consortium," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 14(4), pages 1-17, April.
- Simone A. Huygens & Isaac Corro Ramos & Carlijn V. C. Bouten & Jolanda Kluin & Shih Ting Chiu & Gary L. Grunkemeier & Johanna J. M. Takkenberg & Maureen P. M. H. Rutten-van Mölken, 2020. "Early cost-utility analysis of tissue-engineered heart valves compared to bioprostheses in the aortic position in elderly patients," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(4), pages 557-572, June.
- Víctor Granados-García & Ana M Contreras & Carmen García-Peña & Guillermo Salinas-Escudero & Hla-Hla Thein & Yvonne N Flores, 2016. "Cost-Effectiveness Analysis of Different Testing Strategies that Use Antibody Levels to Detect Chronic Hepatitis C in Blood Donors," PLOS ONE, Public Library of Science, vol. 11(5), pages 1-12, May.
- Thi-Phuong-Lan Nguyen & E Pamela Wright & Thanh-Trung Nguyen & C C M Schuiling-Veninga & M J Bijlsma & Thi-Bach-Yen Nguyen & M J Postma, 2016. "Cost-Effectiveness Analysis of Screening for and Managing Identified Hypertension for Cardiovascular Disease Prevention in Vietnam," PLOS ONE, Public Library of Science, vol. 11(5), pages 1-17, May.
- Johanna Leväsluoto & Johanna Kohl & Anton Sigfrids & Jussi Pihlajamäki & Janne Martikainen, 2021. "Digitalization as an Engine for Change? Building a Vision Pathway towards a Sustainable Health Care System by Using the MLP and Health Economic Decision Modelling," Sustainability, MDPI, vol. 13(23), pages 1-24, November.
- Han-I. Wang & Alexandra Smith & Eline Aas & Eve Roman & Simon Crouch & Cathy Burton & Russell Patmore, 2017. "Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(2), pages 255-267, March.
- Harvard, Stephanie & Werker, Gregory R. & Silva, Diego S., 2020. "Social, ethical, and other value judgments in health economics modelling," Social Science & Medicine, Elsevier, vol. 253(C).
- Zachary A. Collier & James H. Lambert, 2019. "Principles and methods of model validation for model risk reduction," Environment Systems and Decisions, Springer, vol. 39(2), pages 146-153, June.
- Ankur Pandya & Ashley A Eggman & Hooman Kamel & Ajay Gupta & Bruce R Schackman & Pina C Sanelli, 2016. "Modeling the Cost Effectiveness of Neuroimaging-Based Treatment of Acute Wake-Up Stroke," PLOS ONE, Public Library of Science, vol. 11(2), pages 1-13, February.
- Vojtěch Kamenský & Vladimír Rogalewicz & Ondřej Gajdoš & Gleb Donin, 2022. "Discrete Event Simulation Model for Cost-Effectiveness Evaluation of Screening for Asymptomatic Patients with Lower Extremity Arterial Disease," IJERPH, MDPI, vol. 19(18), pages 1-16, September.
- A C Bouman & A J ten Cate-Hoek & B L T Ramaekers & M A Joore, 2015. "Sample Size Estimation for Non-Inferiority Trials: Frequentist Approach versus Decision Theory Approach," PLOS ONE, Public Library of Science, vol. 10(6), pages 1-14, June.
- L. Standfield & T. Comans & M. Raymer & S. O’Leary & N. Moretto & P. Scuffham, 2016. "The Efficiency of Increasing the Capacity of Physiotherapy Screening Clinics or Traditional Medical Services to Address Unmet Demand in Orthopaedic Outpatients: A Practical Application of Discrete Eve," Applied Health Economics and Health Policy, Springer, vol. 14(4), pages 479-491, August.
- Paul Jülicher & Vladimir P Chulanov & Nikolay N Pimenov & Ekaterina Chirkova & Anna Yankina & Claudio Galli, 2019. "Streamlining the screening cascade for active Hepatitis C in Russia: A cost-effectiveness analysis," PLOS ONE, Public Library of Science, vol. 14(7), pages 1-22, July.
- Eleanor J. Murray, 2020. "Epidemiology's Time of Need: COVID-19 Calls for Epidemic-Related Economics," Journal of Economic Perspectives, American Economic Association, vol. 34(4), pages 105-120, Fall.
- Hossein Haji Ali Afzali & Jonathan Karnon & Olga Theou & Justin Beilby & Matteo Cesari & Renuka Visvanathan, 2019. "Structuring a conceptual model for cost-effectiveness analysis of frailty interventions," PLOS ONE, Public Library of Science, vol. 14(9), pages 1-13, September.
- Rudabeh Meskarian & Marion L Penn & Sarah Williams & Thomas Monks, 2017. "A facility location model for analysis of current and future demand for sexual health services," PLOS ONE, Public Library of Science, vol. 12(8), pages 1-18, August.
- Svenn Alexander Hansen & Eline Aas & Oddvar Solli, 2020. "A cost-utility analysis of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(1), pages 73-84, February.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0110235. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.